This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20171107 arb minutes"
Jump to navigation
Jump to search
m |
|||
| Line 41: | Line 41: | ||
| width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 ARB Work Group Meeting Minutes''' <br/> | | width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 ARB Work Group Meeting Minutes''' <br/> | ||
'''Location: [[spring_ARB_Logistics| Telcon]]''' | '''Location: [[spring_ARB_Logistics| Telcon]]''' | ||
| − | | width="50%" colspan="3" align="left" style="background:#f0f0f0;"|'''Date: | + | | width="50%" colspan="3" align="left" style="background:#f0f0f0;"|'''Date: 20171107'''<br/> '''Time: 4:00pm U.S. Eastern''' |
|- | |- | ||
| width="10%" colspan="1" align="right"|'''Facilitator''' | | width="10%" colspan="1" align="right"|'''Facilitator''' | ||
| − | | width="35%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]] | + | | width="35%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]] |
| width="10%" colspan="1" align="right"|'''Note taker(s)''' | | width="10%" colspan="1" align="right"|'''Note taker(s)''' | ||
| − | | width="30%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]] | + | | width="30%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]] |
|- | |- | ||
| border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"| | | border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"| | ||
| Line 57: | Line 57: | ||
|colspan="2"|NEHTA | |colspan="2"|NEHTA | ||
|- | |- | ||
| − | | | + | |X||[[User:Lconstab |Constable, Lorraine]] |
|colspan="2"|Constable Consulting Inc. | |colspan="2"|Constable Consulting Inc. | ||
|- | |- | ||
| Line 63: | Line 63: | ||
|colspan="2"| AEGIS | |colspan="2"| AEGIS | ||
|- | |- | ||
| − | | | + | |X||[[User:Ajulian | Julian, Tony]] |
|colspan="2"|Mayo Clinic | |colspan="2"|Mayo Clinic | ||
|- | |- | ||
| − | | | + | |R||Knapp, Paul |
|colspan="2"| Pknapp Consulting | |colspan="2"| Pknapp Consulting | ||
|- | |- | ||
| − | | | + | |R||Kubick, Wayne |
|colspan="2"|HL7 CTO | |colspan="2"|HL7 CTO | ||
|- | |- | ||
| Line 78: | Line 78: | ||
|colspan="2"|Accenture | |colspan="2"|Accenture | ||
|- | |- | ||
| − | | | + | |X||Milosevic, Zoran |
|colspan="2"|Deontik Pty Ltd | |colspan="2"|Deontik Pty Ltd | ||
|- | |- | ||
| − | | | + | |X||[[User:Astechishin| Stechishin,Andy]] |
|colspan="2"|CANA Software and Service Ltd. | |colspan="2"|CANA Software and Service Ltd. | ||
|- | |- | ||
|colspan="4" align="center"|Guests | |colspan="4" align="center"|Guests | ||
|- | |- | ||
| − | | | + | |X||Hicks, Peter |
| − | |colspan="2"| | + | |colspan="2"|U.S. CDC |
|- | |- | ||
| − | |.|| | + | |X|| Lamb, Emilie |
| − | |colspan="2"| | + | |colspan="2"| syndromic.org |
| + | |- | ||
| + | |X||Robertson, Scott | ||
| + | |colspan="2"|Kaiser Permanente | ||
|- | |- | ||
|.|| | |.|| | ||
Revision as of 14:58, 8 November 2017
ARB - Meeting (Date in Title)
Agenda
- Call to order
- Roll Call
- Approval of Agenda and Minutes
- Management
- Mission and Charter Review - Due in fall WGM
- Decision Making Procedures review - due in fall WGM
- Governance
- Methodology
- PHER Syndromic Surveillance Messaging Guide Dave Trepanier
- HAVE project
- FHIR Artifact Curation Process: (From Rene Spronk)
- At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
- I asked Lloyd, and he states that the GOM does allow a third party to bring forward an artifact (e.g. en new FHIR resource, a profile) for inclusion in HL7's standard. Let's assume the "international society for peadiatrics" has defined a new FHIR resource or profile; they organize their own test events; dowzens of vendors have implemented it - and all of that without any official involvement of HL7 international. #**Now they bring this artifact to HL7.
- What's the process ArB/TSC would follow in dealing with that artifact? Where would it end up? Would it have draft status within HL7, or will it have some higher maturity level because it has already been implemented/tested? Who will get to decide this?
- (note that some affiliates face this issue regularly, so its not really a hypothetical question). If there are no answers to the above questions, if you were to speculate, how should the process look like ?
- Other business and planning
- Adjournment
Meeting Information
| HL7 ARB Work Group Meeting Minutes Location: Telcon |
Date: 20171107 Time: 4:00pm U.S. Eastern | |||
| Facilitator | Julian, Tony | Note taker(s) | Julian, Tony | |
| Attendee | Name | Affiliation | ||
| . | Bond,Andy | NEHTA | ||
| X | Constable, Lorraine | Constable Consulting Inc. | ||
| . | Hyland, Mario | AEGIS | ||
| X | Julian, Tony | Mayo Clinic | ||
| R | Knapp, Paul | Pknapp Consulting | ||
| R | Kubick, Wayne | HL7 CTO | ||
| . | Loyd, Patrick | ICode Solutions | ||
| . | Lynch, Cecil | Accenture | ||
| X | Milosevic, Zoran | Deontik Pty Ltd | ||
| X | Stechishin,Andy | CANA Software and Service Ltd. | ||
| Guests | ||||
| X | Hicks, Peter | U.S. CDC | ||
| X | Lamb, Emilie | syndromic.org | ||
| X | Robertson, Scott | Kaiser Permanente | ||
| . | ||||
| Legend | ||||
| X | Present | |||
| . | Absent | |||
| R | Regrets | |||
| Quorum Requirements (Co-chair + 3) Met: Yes | ||||
Minutes
Agenda
- Call to order
- Roll Call
- Approval of Agenda and Minutes
- Management
- Mission and Charter Review - Due in fall WGM
- Decision Making Procedures review - due in fall WGM
- Governance
- Methodology
- PHER Syndromic Surveillance Messaging Guide Dave Trepanier
- HAVE project
- FHIR Artifact Curation Process: (From Rene Spronk)
- At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
- I asked Lloyd, and he states that the GOM does allow a third party to bring forward an artifact (e.g. en new FHIR resource, a profile) for inclusion in HL7's standard. Let's assume the "international society for peadiatrics" has defined a new FHIR resource or profile; they organize their own test events; dowzens of vendors have implemented it - and all of that without any official involvement of HL7 international. #**Now they bring this artifact to HL7.
- What's the process ArB/TSC would follow in dealing with that artifact? Where would it end up? Would it have draft status within HL7, or will it have some higher maturity level because it has already been implemented/tested? Who will get to decide this?
- An HL7 WG would create an HL7 project to bring in the material.
- ARB would review
- the external content and the PSS to ensure the content is appropriate
- verify that the appropriate WG's are engaged.
- The material would come in as DRAFT and have to follow the established rules for maturity level.
- (note that some affiliates face this issue regularly, so its not really a hypothetical question). If there are no answers to the above questions, if you were to speculate, how should the process look like ?
- Other business and planning
- Adjournment
- An HL7 Work Group would create an HL7 project to bring in the material.
- ARB would review
- the external content and the Project Scope Statement to ensure the content is appropriate.
- verify that the appropriate Work Groups are engaged.
- The material would come in as DRAFT or STU and have to follow the established rules for balloting and maturity level.
- The fact it has been implemented and tested outside of HL7 is no guarantee that it will test in HL7.
